- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 31.08. | Exousia Bio, Inc. - 15-12G, Securities registration termination | 1 | SEC Filings | ||
| 04.08. | L A M Y: Exousia Bio Nearing Completion of Milestone Multimillion-Dollar Capital Investment | 394 | ACCESS Newswire | Strategic Financing to Accelerate Exosome Pipeline Expansion, International Joint Ventures, and Scale-Up of NexTel Medical (MAJI) ORLANDO, FL / ACCESS Newswire / August 4, 2026 / Exousia Bio, Inc. f/k/a... ► Artikel lesen | |
| 22.07. | Exousia Pro, Inc.: NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform | 280 | GlobeNewswire (Europe) | Revised transaction expands NexTel's acquisition from JumpstartRx and NuevistraMed to Island 40 Group's broader growth platform, adding health services, pharmaceutical access, lab testing, institutional... ► Artikel lesen | |
| 16.06. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 09.06. | Exousia Pro, Inc.: NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University | 825 | GlobeNewswire (Europe) | Led by Scientific Advisory Board Members Dr. John Bitzer and Dr. Marvin Hausman, the Study Utilizes Advanced Mass Spectrometry to Identify the Precise Bioactive Healing Compounds Within Proprietary... ► Artikel lesen | |
| 02.06. | Exousia Pro, Inc.: NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome Commercialization | 322 | GlobeNewswire (Europe) | Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026... ► Artikel lesen | |
| 11.05. | Exousia Pro, Inc.: NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist | 317 | GlobeNewswire (Europe) | ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery... ► Artikel lesen | |
| 16.03. | Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value | 572 | GlobeNewswire (Europe) | ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 05.03. | Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions | 199 | GlobeNewswire (Europe) | ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce... ► Artikel lesen | |
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 542 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 518 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 610 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 441 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 593 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 728 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 557 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 261,10 | -1,36 % | EQS-News: SARTORIUS Aktiengesellschaft: Sartorius setzt positive Umsatz- und Margenentwicklung in starken ersten neun Monaten fort | EQS-News: SARTORIUS Aktiengesellschaft
/ Schlagwort(e): 9-Monatszahlen
Sartorius setzt positive Umsatz- und Margenentwicklung in starken ersten neun Monaten fort (News mit Zusatzmaterial)
22.10.2026... ► Artikel lesen | |
| 2G ENERGY | 46,740 | +3,27 % | Wo Meilensteine und Prognosen neue Dynamik entfachen - ElringKlinger, 2G Energy, RE Royalties | Ob wachsende Zweifel bei einem Energieunternehmen, innovative Finanzierungsmodelle im globalen Energiemarkt oder optimistischer werdende Prognosen im automobilen Wandel. Drei börsennotierte Akteure... ► Artikel lesen | |
| UNUSUAL MACHINES | 17,000 | +0,09 % | Unusual Machines, Inc.: Unusual Machines Completes Acquisition of Upgrade Energy, Expanding U.S. Drone Battery Manufacturing | Adds high-performance battery and power systems to Unusual Machines' portfolio of critical drone components ORLANDO, FL / ACCESS Newswire / October 19, 2026 / Unusual Machines, Inc. (NYSE American:UMAC)... ► Artikel lesen | |
| PVA TEPLA | 30,320 | +2,16 % | EQS-PVR: PVA TePla AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: PVA TePla AG
PVA TePla AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| EVOLV TECHNOLOGIES | 4,435 | +0,34 % | Why Investors are Ignoring Growth at Evolv Technologies Holdings (EVLV) | ||
| LIGHTWAVE LOGIC | 4,425 | 0,00 % | Starke Ansage vom Chef: Bis 2029 ausverkauft! Dieser Nvidia-Partner kann sich vor Aufträgen kaum retten | © Foto: KI-generiert mit DALL-EDer KI-Boom erreicht eine neue Dimension: Lumentum ist bis Anfang 2029 ausverkauft. Bei einigen Produkten kann der Nvidia-Partner 70 Prozent der Nachfrage nicht bedienen.... ► Artikel lesen | |
| GPGI | 12,925 | 0,00 % | CompoSecure, Inc.: CompoSecure eröffnet neues London Design Centre, um die wachsende internationale Nachfrage nach Premiumkarten aus Metall zu erfüllen | Neues Client Studio in unmittelbarer Nähe der Tower Bridge ermöglicht Kartenanbietern, Metallkartenprogramme in Echtzeit und persönlich zu entwerfen, zu testen, zu bemustern und zu veredelnLONDON, Oct.... ► Artikel lesen | |
| HUDSON TECHNOLOGIES | 5,410 | 0,00 % | Hudson Technologies Reports First Quarter 2026 Results | First Quarter 2026 Financial Highlights Revenue increased 9% to $60.2 million 20% sales volume growthShare repurchases of $2.5 millionHFC prices firming above $6 per pound WOODCLIFF LAKE, N.J., May... ► Artikel lesen | |
| SERVE ROBOTICS | 3,055 | -0,16 % | Serve Robotics Inc.: Serve Robotics Announces Second Quarter 2026 Results | Delivered over 400% revenue growth in Q2 year over year as diverse portfolio of revenue across delivery, branding, and software grew strong triple digits compared to a year ago. Further diversified... ► Artikel lesen | |
| AIRJOULE TECHNOLOGIES | 3,060 | 0,00 % | AirJoule Technologies Corporation: AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business | Acquisition complements AirJoule Technologies' water technology with BitSink's well-established cooling solutions to address the critical infrastructure requirements of next-generation modular data... ► Artikel lesen | |
| ITURAN LOCATION AND CONTROL | 50,91 | +0,12 % | Ituran Location & Control Ltd. - 6-K, Report of foreign issuer | ||
| SONO-TEK | 5,140 | -0,96 % | Sono-Tek outlines facility expansion to lift manufacturing capacity to $33M-$36M, with plan toward $44M-$45M | ||
| RCM TECHNOLOGIES | 37,900 | -0,08 % | RCM Technologies, Inc. Announces Second Quarter 2026 Results | PENNSAUKEN, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through... ► Artikel lesen | |
| PFEIFFER VACUUM TECHNOLOGY | 165,40 | 0,00 % | EQS-PVR: Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Pfeiffer Vacuum Technology AG
Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading... ► Artikel lesen | |
| ZEBRA TECHNOLOGIES | 348,00 | -0,29 % | Zebra Technologies: Die Augen der Roboter - die nächste KI-Chance? |
Das Unternehmen EXOUSIA ADVANCED MATERIALS INC kann der Branche Sonstige Technologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.